66 results
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
sheath (NBDS) cells within the hair follicle that are replicated in culture. These fibroblasts are efficient producers of type I collagen and because … they are of anagen hair follicle mesenchymal origin, they have the potential to replicate efficiently in culture. The use of these fibroblasts
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
(NBDS) cells within the hair follicle that are replicated in culture. These fibroblasts are efficient producers of type I collagen and because … they are of anagen hair follicle mesenchymal origin, they have the potential to replicate efficiently in culture. The use of these fibroblasts are, therefore
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
culture that is committed to maintaining quality financial reporting, sound business risk practices and ethical behavior within the Company. In addition
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
in culture. These fibroblasts are efficient producers of type I collagen and because they are of anagen hair follicle mesenchymal origin, they have … the potential to replicate efficiently in culture. The use of these fibroblasts are, therefore, ideal for treating chronic tendon disorders that arise due
6-K
EX-99.2
m66h9taji4tox3xejlb6
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
20-F/A
3a9tm
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.2
ngdbm22
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.4
89bkvbrnocv
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.2
uyw0jazbwc5z1wwu5c
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
0rtc0 ndbaz7h
18 Nov 21
Notice of Annual General and Special Meeting of Shareholders
10:36am
6-K
EX-99.1
ohip6e3j55fi3ec
12 Oct 21
RepliCel and University of Victoria Collaboration Leads to Bioengineering Innovations, Funding, and Patents
1:06pm
6-K
EX-99.2
rfcduwdeeidtw
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
ozvfx0q77xnahnzo
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.2
x12h74kvt9v2y2pc6f3
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
20-F/A
gs0xx
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.3
8cxu19pah3j8c0
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.2
c8zfbr 52libcsx
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm